Apichope Pharmaceutical's Subsidiary Secures Registration Certificate for Procaterol Hydrochloride Oral Solution

Stock News

06/22

The wholly-owned subsidiary of Apichope Pharmaceutical Group Co.,Ltd. (ASX: 300723), Guangzhou Apichope Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for Procaterol Hydrochloride Oral Solution, approved and issued by the National Medical Products Administration.

This pharmaceutical product is intended for the relief of symptoms such as breathing difficulties caused by respiratory obstructive disorders associated with the following diseases: bronchial asthma, chronic bronchitis, acute bronchitis, and asthmatic bronchitis.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1177970818"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177970818\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177970818?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 16:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177970818","market":"hk","top_or_hot":-1,"title":"Apichope Pharmaceutical's Subsidiary Secures Registration Certificate for Procaterol Hydrochloride Oral Solution","media":"Stock News","content":"<p>The wholly-owned subsidiary of <b>Apichope Pharmaceutical Group Co.,Ltd.</b> (<b>ASX: 300723</b>), Guangzhou Apichope Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for Procaterol Hydrochloride Oral Solution, approved and issued by the National Medical Products Administration.<br><br>This pharmaceutical product is intended for the relief of symptoms such as breathing difficulties caused by respiratory obstructive disorders associated with the following diseases: bronchial asthma, chronic bronchitis, acute bronchitis, and asthmatic bronchitis.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apichope Pharmaceutical's Subsidiary Secures Registration Certificate for Procaterol Hydrochloride Oral Solution</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApichope Pharmaceutical's Subsidiary Secures Registration Certificate for Procaterol Hydrochloride Oral Solution\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time smaller\">2026-06-22 16:14</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>The wholly-owned subsidiary of <b>Apichope Pharmaceutical Group Co.,Ltd.</b> (<b>ASX: 300723</b>), Guangzhou Apichope Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for Procaterol Hydrochloride Oral Solution, approved and issued by the National Medical Products Administration.<br><br>This pharmaceutical product is intended for the relief of symptoms such as breathing difficulties caused by respiratory obstructive disorders associated with the following diseases: bronchial asthma, chronic bronchitis, acute bronchitis, and asthmatic bronchitis.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300723","symbol_name":"一品紅","start_time":0,"source_url":"","article_id":"1177970818","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177970818","pubTimestamp":1782116072,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"The wholly-owned subsidiary of Apichope Pharmaceutical Group Co.,Ltd. (ASX: 300723), Guangzhou Apichope Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300723":"一品红","BK4202":"服装、服饰与奢侈品","BK0239":"医药制造","CRI":"卡特"},"translate_title":"Apichope Pharmaceutical子公司获得盐酸丙卡特罗口服溶液注册证","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300723":1,"CRI":1},"content_text":"The wholly-owned subsidiary of Apichope Pharmaceutical Group Co.,Ltd. (ASX: 300723), Guangzhou Apichope Pharmaceutical Co., Ltd., has recently received the Drug Registration Certificate for Procaterol Hydrochloride Oral Solution, approved and issued by the National Medical Products Administration.This pharmaceutical product is intended for the relief of symptoms such as breathing difficulties caused by respiratory obstructive disorders associated with the following diseases: bronchial asthma, chronic bronchitis, acute bronchitis, and asthmatic bronchitis.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}